Disease-Free Survival
Research News and Information

Saturday, November 21, 2009

Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).

13 Dec 2009 BACKGROUND: Allogeneic hematopoietic cell transplant (HCT) with best available donor for children with Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) has previously been considered standard practice. Since the introduction of ... Read more...

A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.

13 Dec 2009 An asymptomatic 11-week-old male received no treatment after he was classified as having a suspected atypical form of MYCN-nonamplified hyperdiploid stage 4S neuroblastoma (NB), with masses in an adrenal gland, subcutaneous tissues, and the falx ... Read more...

Natural history and outcome of optic pathway gliomas in children.

13 Dec 2009 BACKGROUND: The optimal management of optic pathway gliomas (OPGs) is complicated by their variable natural history, the association with neurofibromatosis type 1 (NF1) and difficulties in defining progression and response to treatment. METHODS: ... Read more...

Latest indexed articles for 'Disease-Free Survival'

These are the very latest articles for this heading:

• Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). 13 Dec 2009
• A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy. 13 Dec 2009
• Natural history and outcome of optic pathway gliomas in children. 13 Dec 2009
• Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer. 29 Nov 2009
• WT1 expression at diagnosis does not predict survival in pediatric AML: a report from the Children's Oncology Group. 29 Nov 2009
• The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma. 18 Nov 2009
• Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. 3 Nov 2009
• Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy. 30 Oct 2009
• Mucin-containing Rokitansky-Aschoff sinuses with extracellular mucin deposits simulating mucinous carcinoma of the gallbladder. 30 Oct 2009
• Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant. 30 Oct 2009
• Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST. 30 Oct 2009
• Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. 30 Oct 2009
• Does the negative node count affect disease-free survival in early-stage oral cavity cancer? 30 Oct 2009
• Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer. 30 Oct 2009
• Progression-free survival remains debatable endpoint in cancer trials. 12 Oct 2009
• Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. 11 Oct 2009
• Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. 11 Oct 2009
• Outcome and prognostic factors on 57 cases of infective endocarditis in a single centre. 7 Oct 2009
• Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial. 4 Oct 2009
• Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. 4 Oct 2009

See a longer list of these articles.

Technical information about 'Disease-Free Survival'

Definition: Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.

Descriptor UI: D018572

Alternative terms: Disease-Free Survival; Disease Free Survival; Event-Free Survival; Event Free Survival; Event-Free Survivals; Survival, Event-Free; Survivals, Event-Free; Survival, Disease-Free; Disease-Free Survivals; Survival, Disease Free; Survivals, Disease-Free; Progression-Free Survival; Progression Free Survival; Progression-Free Survivals; Survival, Progression-Free; Survivals, Progression-Free;

Tree Number: E01.789.200; E05.318.740.998.300; N05.715.360.750.795.300; N06.850.520.830.998.300;

History Note: 95

Technical Notes: after successful ther; never IM; coord NIM with specific dis /ther or more specific qualif (IM); DF: DIS FREE SURVIVAL